India's key stock indices declined on Tuesday, with most sectors in the red, primarily due to a drop in pharma stocks ...

Indian benchmark indices Nifty 50 and Sensex ended the previous session higher. Nifty 50 closed at 24,461.15, while Sensex ...

India's benchmark indexes traded lower on Tuesday, as broader losses led by pharma stocks on U.S. manufacturing measures ...

The pharma stocks in India see significant selloff after US President Donald Trump signs executive orders promoting active ...

On Monday, Indian benchmarks registered strong gains, with the Sensex closing nearly 295 points higher, reaching its highest level for 2025, powered by robust foreign institutional investor (FII) ...

India's benchmark indexes opened little changed on Tuesday, as a drop in drug makers on measures to boost U.S. manufacturing ...

All eyes on the Ather Energy listing in a short while from now. The Grey Market Premium indicates listing at a slight premium ...

Application error: a client-side exception has occurred (see the browser console for more information).

Alembic Pharmaceuticals Ltd. is projected to report revenue of Rs 1,646.1 crore, with a net profit of Rs 148.8 crore. The ...

Foreign portfolio investors stayed net buyers of Indian equities for the 13th straight session, as they bought stocks worth ...

Equity benchmarks rise on strong auto and energy sectors, Adani stocks surge, Nifty faces resistance at 24,500 levels.